Ayati Devices: Saving lives with Innovation!

The World Health Organization has recognized diabetes as the ninth leading cause of death worldwide, with an estimated one million deaths each year. With every seventh person being diabetic, India ranks as the world’s second-largest country in the global diabetes epidemic.

This chronic health condition gives rise to many fatal diseases that can damage the kidneys, nerves, blood vessels and heart. Many diabetic patients suffer from Peripheral neuropathy- a condition which arises from the damage of nerves in the hands and feet, causing numbness, pain, and loss of sensation.  This condition can turn terminal if not diagnosed and treated on time. If left ignored, poor blood circulation and weak immunity might increase the risk of an ulcer which can also result in amputation. Hence, diabetic patients must get their neuropathy screening, and treatment is done on time.

Founded in 2019, Ayati Devices is diligently bouncing ideas to make the screening of diabetic neuropathic patients effortless, accurate, affordable and accessible. The startup is the brainchild of Nishant Kathpal, who is passionate about learning new technology, and innovation and explores constructive approaches to help solve real-life challenges. With a team of experts from diverse professional backgrounds, he is giving shape to his idea of developing an innovative diabetic foot screener which helps clinicians to save time while maintaining accuracy. This diabetic foot screener is designed to support the patients to monitor the problem which further aids their treatment.

Ayati flagship offerings:

• VIBRASENSE: A portable point-of-care device to screen and monitor diabetic patients for foot neuropathy at an early stage to prevent foot. The device is useful for OPDs, paying home visits, and screening camps.
• NEUMU: An automatic device that is capable of doing the comprehensive analysis of the foot including quantification of Pressure, Vibration & Temperature Perception Threshold and accurately diagnosing diabetic patients for peripheral neuropathy.
• STIMU: This advanced technology is Portable, Automatic and Non-Subjective and has the potential of screening and diagnosing foot ulcer at early stage. It examines the tissues of the patient’s foot sole to only codify them into risk & no-risk zones.

The company is virtually incubated at the Center of Excellence – IoT & AI, Gurugram, which is a Joint initiative of the Ministry of Electronics & IT (MeitY), Govt. of Haryana, and NASSCOM.

This healthcare startup’s remarkable invention NEUMU takes less than five minutes to diagnose a diabetic patient for neuropathy at an early stage to prevent foot amputations. It quantifies three major parameters. Ayati’s unique solution VIBRASENSE is a battery-powered portable quick screening device that helps in screening and detecting peripheral neuropathy. The algorithm of this technology is designed to analyse patients and classify them into three risk categories that are low, medium and high. The controlled stimulus of this wireless device can be used to find out the loss of sensation on the foot. It can be easily connected with applications for report generation and monitoring purposes. VIBRASENSE has surmounted all scrutinies and has been certified with IEC standards and it stands to be one of the most trusted and preferred Indian CE-marked & CDSCO approved biothesiometer. To date, with the help of this unique solution, Ayati has been able to conduct the screening of more than 100K patients.

Ayati’s brilliant inventiveness had lighted up their way to significant recognition and success. The team was bestowed with opportunities to showcase their innovation on global platforms, including the International Tech Hub by the UK government and the Dubai Expo. They were among the top finalists in the LKYG Business Plan in Singapore and won prestigious titles BIRAC BIG, BIPP, “Best start-up award” in Spain, and the “Best IoT medical device award” at Indian IoT Congress. The team raised a good amount of grants and awards which counts to about 1.5Cr.

To date, Ayati’s devices have been involved in three major screening camps namely the Maharashtra (Shegaon and Chandrapur) Camp, where they have conducted low-cost screening of more than 500 patients, helping them with early diagnosis and timely treatment of any kind of foot malady. The team showed commendable participation in supporting the purpose of the Niramaya Gujarat Program and screened 37 Diabetic patients, out of which 29 tested positive for the diabetic foot.

For the future, Ayati Devices has set their sight on becoming the leading provider of first level of innovation and affordable healthcare monitoring solutions across the globe. Abiding by their motto, the team is working like a Trojan to enable effective screening accessible and affordable for every diabetic patient, especially for those suffering with neuropathy and they plan to do this with the support of VIBRASENSE.  In the time to come, Ayati envisages to grow both nationally and worldwide with targets set to launch itself in the diverse market of Middle East Asia and Africa.

“With NASSCOM CoE, Ayati is exploring multiple opportunities with the partners associated with them. These opportunities will help Ayati in scaling up, growth, and attaining much needed momentum,”- Nishant Kathpal, Founder, Ayati Devices.